Panel Discussion: Scaling Up & Meeting Oligonucleotide Demand

Time: 11:30 am
day: Day Two


• Moving into non-rare disease areas and producing oligonucleotides at scale for larger populations

• Evaluating technologies and the advantages and limitations of scale

• Analytical readiness for process change and late phase: strategic, regulatory, and technical perspectives